This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. It is often employed in the development of drugs targeting the central nervous system, particularly for conditions like anxiety, depression, and other neurological disorders. Its structural features, including the trifluoromethyl group and piperidine moiety, make it a valuable building block for creating molecules with enhanced bioavailability and receptor-binding affinity. Additionally, it is explored in the design of compounds with potential anti-inflammatory and analgesic properties. Researchers also investigate its use in the optimization of drug candidates for improved pharmacokinetic profiles.